Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€32.66
18.11.20
€60.00
18.11.21
-3.60%
30.11.20

Could be worthwhile Investment >10% per year
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.66
18.11.20
€1.00
18.11.21
25.80%
30.11.20

Could be worthwhile Investment >10% per year
buy
Arca Biopharma

Start price
Target price
Perf. (%)
€3.36
18.11.20
€5.00
18.11.21
5.36%
30.11.20

Could be very worthwhile Investment >20% year
buy
SELLAS Life Sciences Group Inc

Start price
Target price
Perf. (%)
€2.39
18.11.20
€4.00
30.50%
30.11.20

Could be worthwhile Investment >10% per year
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.00
18.11.20
€82.00
18.11.21
-10.59%
12.09.21

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.21
18.11.20
€5.00
-7.09%
30.11.20

Risky Investment
buy
MagForce AG

Start price
Target price
Perf. (%)
€3.01
18.11.20
€4.00
18.11.21
12.29%
19.11.21

Could be worthwhile Investment >10% per year
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€39.00
17.11.20
-
17.11.21
-1.74%
07.06.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Little Investments for future growth
Sunwin Stevia Intl.

Start price
Target price
Perf. (%)
€0.055
17.11.20
€0.000
17.11.21
-41.82%
18.11.21

buy
Biofrontera AG

Start price
Target price
Perf. (%)
€3.01
17.11.20
-
17.11.21
-37.10%
18.11.21

buy
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€60.55
16.11.20
€105.00
16.11.21
-10.40%
28.11.20

Could be worthwhile Investment >10% per year
Good rating
Differentiated customer and product portfolio
Risky balance sheet
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€4.16
16.11.20
-
16.11.21
15.87%
03.02.21

buy
Medigene AG

Start price
Target price
Perf. (%)
€3.95
16.11.20
-
16.11.21
-6.46%
27.11.20

buy
Adocia

Start price
Target price
Perf. (%)
€7.54
16.11.20
€10.00
16.11.21
18.04%
17.11.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.20
16.11.20
-
16.11.21
-77.34%
17.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€25.50
16.11.20
-
16.11.21
-60.78%
17.11.21

Probably not worthwhile Investment
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.45
16.11.20
-
16.11.21
-14.81%
17.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Nanorepro AG

Start price
Target price
Perf. (%)
€3.36
16.11.20
-
16.11.21
0.60%
26.11.20

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

buy
Evolus Inc

Start price
Target price
Perf. (%)
€2.97
16.11.20
-
5.78%
30.11.20

buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€4.35
16.11.20
-
16.11.21
23.68%
07.12.20

buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€7.30
15.11.20
€8.00
-4.11%
29.11.20

Risky Investment
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€24.62
15.11.20
€25.00
-3.98%
29.11.20

Could be worthwhile Investment >10% per year
buy
Innate Pharma

Start price
Target price
Perf. (%)
€4.10
15.11.20
€5.50
15.11.21
7.86%
16.11.21

Could be worthwhile Investment >10% per year
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.54
15.11.20
-
15.11.21
-29.53%
16.11.21